Data Year:

For its 2024 fiscal year, WAVE LIFE SCIENCES LTD, listed the following executives on its annual proxy statement to the SEC

Equity
Cash Compensation
Other
Fiscal Year Ended in 2024
Name And Title Total Compensation Pay Rank By Title In Biotechnology industry
Christopher Francis Ph.D.
Senior Vice President, Corporate Development and Head of Emerging Areas
Total Compensation $1,566,422 View details Pay Rank By Title In Biotechnology industry #11 View more
Chandra Vargeese Ph.D.
Chief Technology Officer, Head of Platform Discovery Sciences
Total Compensation $1,888,563 View details Pay Rank By Title In Biotechnology industry #12 View more
Paul B. Bolno M.D., MBA
President and Chief Executive Officer
Total Compensation $4,272,300 View details Pay Rank By Title In Biotechnology industry #293 View more
Kyle Moran CFA
Chief Financial Officer
Total Compensation $1,917,381 View details Pay Rank By Title In Biotechnology industry #242 View more

The charts on this page feature a breakdown of the total annual pay for the top executives at WAVE LIFE SCIENCES LTD as reported in their proxy statements.

Total Cash Compensation information is comprised of yearly Base Pay and Bonuses. WAVE LIFE SCIENCES LTD income statements for executive base pay and bonus are filed yearly with the SEC in the edgar filing system. WAVE LIFE SCIENCES LTD annual reports of executive compensation and pay are most commonly found in the Def 14a documents.

Total Equity aggregates grant date fair value of stock and option awards and long term incentives granted during the fiscal year.

Other Compensation covers all compensation-like awards that don't fit in any of these other standard categories. Numbers reported do not include change in pension value and non-qualified deferred compensation earnings.

Name And Title Total Cash Equity Other Total Compensation
Christopher Francis Ph.D.
Senior Vice President, Corporate Development and Head of Emerging Areas
Total Cash $684,850 Equity $870,312 Other $11,260 $1,566,422
Chandra Vargeese Ph.D.
Chief Technology Officer, Head of Platform Discovery Sciences
Total Cash $775,515 Equity $1,099,134 Other $13,914 $1,888,563
Paul B. Bolno M.D., MBA
President and Chief Executive Officer
Total Cash $1,188,100 Equity $3,064,934 Other $19,266 $4,272,300
Kyle Moran CFA
Chief Financial Officer
Total Cash $776,875 Equity $1,128,914 Other $11,592 $1,917,381
For its 2024 fiscal year, WAVE LIFE SCIENCES LTD, listed the following board members on its annual proxy statement to the SEC.
Name Total COMPENSATION
Adrian Rawcliffe Total Cash $253,091
Aik Na Tan Total Cash $236,216
Christian Henry Total Cash $286,216
Gregory L. Verdine, Ph.D. Total Cash $234,341
Heidi L. Wagner, J.D. Total Cash $438,096
Ken Takanashi Total Cash $234,341
Mark H.N. Corrigan, M.D. Total Cash $447,471
Peter Kolchinsky, Ph.D. Total Cash $234,341
Browse Board of Directors By First Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Browse Executives by First Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Browse Companies by Company Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

This report is not for commercial use. Thorough reviews have been conducted to assure this data accurately reflects disclosures. However for a complete and definitive understanding of the pay practices of any company, users should refer directly to the actual, complete proxy statement.

Use of Data / Disclaimer

The information shown here is a reporting of information included in the company's proxy statement. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information. For those interested in conducting a detailed compensation analysis, we recommend that you review the entire proxy statement. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov and entering the company's name and then looking in the first column for an entry of "Form DEF 14A" (or any similar code). You may also find the annual proxy statement by going directly to the company's website.

What is a proxy statement?

A proxy statement (or "proxy") is a form that every publicly traded U.S. company is required to file with the U.S. Securities & Exchange Commission (SEC) within 120 days after the end of its fiscal year. The proxy must be sent to every shareholder in advance of the company's annual shareholders meeting. All proxy statements are public filings made available to the general public by the SEC.

The proxy statement's main purpose is to alert shareholders to the annual meeting and provide them information about the issues that will be voted on during the annual meeting, including decisions such as electing directors, ratifying the selection of auditors, and other shareholder-related decisions, including shareholder-initiated initiatives. Also, proxies must disclose specific detailed information regarding the pay practices for certain executives.